Microbiome NewsWalk down any supplement aisle and you’ll see the legacy of the loose definition: bottles listing a genus, maybe a species, a big “billions of CFU” number and little else. That tells you about as much as a wine label that says only “grapes.”
It matters because the biology is strain-specific. Two strains of the same species can carry meaningfully different genes and do meaningfully different things. “Contains Lactobacillus” is a category, not a claim. The shift now underway is toward naming the exact strain, characterizing what it does, and proving the organism in the capsule is the one on the label.
What “precision” actually requires
Definition. A specific, sequenced strain with a stable identity — not a genus, not a hidden “proprietary blend.”
Characterization. Knowing what the strain does — which fibers it uses, which metabolites it produces, how it behaves alongside the community already present.
Verification. Confirming, at manufacture, that the product contains the live, defined organism at the stated dose — and that it survives to where it needs to act.
The promise of the next decade isn’t more bacteria. It’s knowing exactly which ones, exactly what they do, and being able to prove it.
You can see the shift on the shelf. A wave of consumer brands now lead with defined, named strains and stated functions rather than a bare CFU count — among them Seed, Pendulum, and Flore’s direct-to-consumer line GoodOnes, which sells targeted, goal-specific formulas. When naming the exact strain becomes a marketing advantage rather than a footnote, the category is maturing.
The honest caveats
None of this makes precision probiotics a cure-all, and the gap between a well-characterized strain and a demonstrated outcome in a real population is still wide. Rigor at the bench is necessary, not sufficient; the clinical evidence has to follow. But the direction of travel — away from vague reassurance, toward claims that can be checked — is healthy.